​Nanjing Forssmann Medical Technology Co., Ltd.

Nanjing Forssmann Medical Technology Co., Ltd. was established in Sept 2014 with a registered capital of 32.33 million yuan. It is located in  Nanjing Biotech and pharmaceutical Valley, Nanjing Jiangbei New area. It is an advanced medical imaging, diagnosis and information technology solution provider. In July 2016, the National Key R&D Program of Digital Diagnosis and Treatment Equipment was approved and it will undertake the project of Development of Intravascular Polarization Sensitive Optical Cocoherence Tomography System (Project No. 2016YFC0100500). In Nov 2016, the company's products passed the special approval of innovative medical devices (No.201600115). The company won the title of Jiangsu technology-based small and medium-sized enterprise in Dec 2016 and Private Science and Technology Enterprise of Jiangsu Province in 2017 and Jiangsu Postgraduate Workstation jointly established with Nanjing University was approved too. By the end of 2016, Forssmann completed the construction of a factory in NJBPV that fully conforms to GMP standards, covering a total area of 2300㎡, including a 10,000-grade clean production workshop of 348㎡, a complete set of microbiology, physicochemical laboratory and related facilities, which passed the clean room environmental test in Feb 2017 and has now been put into normal use.
 
Most of the Forssmann's R&D employees have a bachelor's degree or above, covering management, materials, electronics, machinery, medicine and other fields. Forssmann has established a long-term industry-university-research cooperation foundation with Nanjing University, which not only regularly holds FORSSMANN Medical Engineering Lecture Forum, but also sets up FORSSMANN Medical Engineering International Exchange Fund. In Feb 2016, it signed an industry-university-research cooperation agreement with School of Modern Engineering and Applied Science of Nanjing University.
 
In addition, its joint application has been approved for the national key R&D plan with many scientific research and medical institutions, such as Shanghai Jiaotong University and the General Hospital of the Chinese People's Liberation Army. It also cooperates with the General Hospital of Nanjing Military Region and other units to carry out animal tests for the products under research. Its research project Endovascular Tomography Imaging System and the Catheter was formally established in Dec 2014, which conforms to the high-tech fields of the national key support the category of traditional Chinese medicine imaging technical regulations. The project has now completed registration test and animal experiments, becoming the 86th class-3 medical device specially approved by the Center of Medical Device of the China Food and Drug Administration.
 
Forssmann is now conducting pilot production and process validation in the newly built plant, and plans to start clinical trials at the end of May. It is expected to complete the construction of the quality system and obtain the product registration certificate by the end of 2020. This product will make full advantage of the technology and domestic equipment,  significantly reduce the price of equipment and catheter and increase its market share under the premise of guaranteeing the same efficacy as certain foreign products. On the basis of a complete set of quality hardware and software and positive cooperation of industry-university-research, some company shareholders have China's senior enterprises in the field of commercial circulation of heart head blood-vessela and cerebrovascular. With their enterprises' products high domestic market share, these shareholders can make the company brand and product promotion and marketing to promote effectively by using their rich market experience and marketing channel.
 
In addition, Forssmann reserves a large number of senior practitioners for marketing and promotion in the field of top 500 international medical devices. Moreover, the national industrial policy and medical insurance support for domestic high-end medical devices also have great benefits for the development of the company. Forssmann will strive to improve the market share of its products by self-requirements of the international leading level, to increase the introduction of all kinds of professional and technical personnel to ensure the implementation of the company's strategic development in the future.